Core One Labs Inc (CLABF)
0.0924
+0.01
(+10.70%)
USD |
OTCM |
Sep 27, 14:18
Core One Labs Enterprise Value: 4.003M for Sept. 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 26, 2024 | 4.003M |
| September 25, 2024 | 2.898M |
| September 24, 2024 | 2.898M |
| September 23, 2024 | 5.512M |
| September 20, 2024 | 5.512M |
| September 19, 2024 | 4.605M |
| September 18, 2024 | 4.113M |
| September 17, 2024 | 3.524M |
| September 16, 2024 | 3.373M |
| September 13, 2024 | 3.373M |
| September 12, 2024 | 5.111M |
| September 11, 2024 | 3.369M |
| September 10, 2024 | 5.577M |
| September 09, 2024 | 3.840M |
| September 06, 2024 | 3.840M |
| September 05, 2024 | 3.840M |
| September 04, 2024 | 3.840M |
| September 03, 2024 | 5.342M |
| August 30, 2024 | 5.342M |
| August 29, 2024 | 5.011M |
| August 28, 2024 | 7.315M |
| August 27, 2024 | 6.194M |
| August 26, 2024 | 3.136M |
| August 23, 2024 | 1.489M |
| August 22, 2024 | 3.371M |
| Date | Value |
|---|---|
| August 21, 2024 | 1.485M |
| August 20, 2024 | 1.296M |
| August 19, 2024 | 5.067M |
| August 16, 2024 | 4.706M |
| August 15, 2024 | 4.494M |
| August 14, 2024 | 4.638M |
| August 13, 2024 | 4.640M |
| August 12, 2024 | 4.942M |
| August 09, 2024 | 4.951M |
| August 08, 2024 | 5.174M |
| August 07, 2024 | 5.174M |
| August 06, 2024 | 4.414M |
| August 05, 2024 | 5.142M |
| August 02, 2024 | 4.711M |
| August 01, 2024 | 4.711M |
| July 31, 2024 | 4.673M |
| July 30, 2024 | 4.673M |
| July 29, 2024 | 4.673M |
| July 26, 2024 | 3.227M |
| July 25, 2024 | 3.227M |
| July 24, 2024 | 3.755M |
| July 23, 2024 | 3.755M |
| July 22, 2024 | 3.345M |
| July 19, 2024 | 3.345M |
| July 18, 2024 | 3.345M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.167M
Minimum
May 18 2020
109.65M
Maximum
Feb 10 2021
20.22M
Average
12.45M
Median
Enterprise Value Benchmarks
| Acasti Pharma Inc | 11.87M |
| Aurinia Pharmaceuticals Inc | 693.34M |
| Edesa Biotech Inc | 12.02M |
| Lexaria Bioscience Corp | 37.60M |
| InMed Pharmaceuticals Inc | -5.554M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.6175M |
| Revenue (Quarterly) | 0.0688M |
| Total Expenses (Quarterly) | 0.3829M |
| EPS Diluted (Quarterly) | -0.0147 |
| Profit Margin (Quarterly) | -897.5% |
| Earnings Yield | -81.21% |
| Normalized Earnings Yield | -59.47 |